期刊文献+

乳腺癌组织中Dab1蛋白表达及其临床相关性研究 被引量:1

Expression and clinical value of Disabled-1 in breast cancer
下载PDF
导出
摘要 目的探讨Disabled-1(Dab1)在乳腺癌组织中的表达情况及其临床意义。方法采用免疫组织化学检测50例乳腺癌组织和相应癌旁正常组织中Dab1表达水平,并分析其表达与患者临床病理特征的关系;通过Oncomine数据库分析Dab1 m RNA在乳腺癌中的表达情况;下载GEO数据库中乳腺癌基因表达数据,采用Kaplan-Meier法分析Dab1的表达水平与乳腺癌患者预后的关系。结果乳腺癌组织中Dab1阳性表达率48.00%(24/50),癌旁组织中Dab1的阳性表达率为82.00%(42/50),两者阳性率的差异有统计学意义(χ~2=100.00,P=0.000);Dab1蛋白表达与乳腺癌患者的年龄、月经状态、肿瘤大小、病理类型无关(P>0.05),但与患者的肿瘤分化程度、TNM分期、淋巴结转移有关(P<0.05)。结论 Dab1蛋白在乳腺癌组织中表达降低,且与患者的肿瘤分化程度、TNM分期、淋巴结转移有关。 Objective To study the expression of Disabled-1(Dab1) protein in breast cancer and the potential correlation with clinical prognosis. Methods Totally 50 cases of patients with breast cancer were involved in this study. Expression of Dab1 in cancer tissue and nearby normal tissues was detected with immunohistochemistry. The relationship between expression of Dab1 and clinical characteristics was analyzed. m RNA levels of Dab1 was analyzed by tumor microarray database(Oncomine). Correlation between expression of Dab1 and prognosis of breast cancer was identified by Kaplan Meier curve. Results The positive rate of Dab1 in breast cancer in cancer group was significantly higher compared with normal group(48.00% vs 82.00%, χ^2 = 100.00, P = 0.000). Expression of Dab1 in breast cancer tissue was positively correlated with tumor differentiation degree, TNM staging and lymph node metastasis(P〈0.05). No obvious correlation was founded between Dab1 and age, menstruation, tumor size or pathological type of tumor. Conclusion Down-regulated of Dab1 breast cancer tissueis correlated with tumor differentiation degree, TNM staging and lymph node metastasis.
作者 王同玫 张一奇 文普帅 毕竟 李锦成 Tong-mei Wang;Yi-qi Zhang;Pu-shuai Wen;Jing Bi;Jin-cheng Li(Department of Breast Surgery, the First Afiated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121001, China;Department of Pathophysiology, Jinzhou Medical University, Jinzhou, Liaoning 121001, China;Laboratory of Neurobiology, Jinzhou Medical University,Jinzhou, Liaoning 121001, China)
出处 《中国现代医学杂志》 CAS 2018年第15期32-36,共5页 China Journal of Modern Medicine
关键词 乳腺癌 Disabled-1 免疫组织化学 breast cancer Disabled-1 immunohistochemistry
  • 相关文献

参考文献5

二级参考文献57

  • 1Sarah F Elliott,George Allen,David J Timson.Biochemical analysis of the interactions of IQGAP1 C-terminal domain with CDC42[J].World Journal of Biological Chemistry,2012,3(3):53-60. 被引量:1
  • 2赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 3谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 4Jemal A,Bray F,Center M M,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2) :69-90.
  • 5Martin A,Corte M D,Alvarez A M,et al.Prognostic value of pre- operative serum CA 15.3 levels in breast cancer[J].Anticancer Res,2006, 26(5B) :3965-3971.
  • 6Velaiutham S,Taib N A,Ng K L,et al.Does the pre-operative val- ue of serum CA15-3 correlate with survival in breast cancer?[J].Asian Pae J Cancer Prev,2008,9(3) :445-448.
  • 7Robertson D M,Pruysers E,Jobling T.Inhibin as a diagnostic marker for ovarian cancer[J].Cancer Lett, 2007,249 ( 1 ) : 14-17.
  • 8Moore R G, MacLaughlan S, Bast R C.Current state of biomarker development for clinical application in epithelial ovarian cancer[J].Gy- necol Oncol, 2010, 116(2) : 240-245.
  • 9Harris L, Fritsche H, Mennel R, et al.American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J].Journal of Clini Oncol, 2007,25 ( 33 ) : 5287-5312.
  • 10Jayasundar JJ, Ju JH, He L.Open conformation of ezrin bound to phos-phatidylinositol 4,5-bisphosphate and to F-actin revealed by neutronscattering [J]. Biol Chem, 2012,287(44):37119-37133.

共引文献1464

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部